us hemodynamic monitoring system Market

The US hemodynamic monitoring system market, is anticipated to reach US$ 486.39 Mn in 2027 from US$ 292.28 Mn in 2019. The market is projected to grow with a CAGR of 6.7% from 2020-2027.

The US hemodynamic monitoring system market is projected to grow owing to some key factors such as increasing product developments and approvals, rising cardiovascular disease prevalence, and growing geriatric population. However, the market is expected to show slower growth due to the risks associated with invasive hemodynamic monitoring systems. Despite the restraining factor, future trend such as increasing trend for noninvasive devices is likely to show impact on the market growth.
The measurement of cardiac functions and blood circulation is called as hemodynamic monitoring. The monitoring allows physicians to estimate the amount of oxygen that is being distributed in tissues and organs of the human body. Hemodynamic monitoring systems are used for measuring blood pressure from inside the veins, arteries, and heart. The hemodynamic monitoring systems are also used to measure blood flow and the level of oxygen in the blood.

The prevalence of cardiovascular diseases in the US, which is the leading cause of death across the country, is much higher; nearly >50% the population is suffering from some or other cardiovascular disease. According to the Centers for Disease Control and Prevention, every year, more than 0.6 million people die due to cardiovascular disease; this nearly accounts for one in every four deaths. The major cause of cardiovascular disease among people is hypertension, obesity, and diabetes. According to data published on January 31, 2019, by American Heart Association, by 2035, over 130 million or 45.1% of people are likely to have some form of cardiovascular disease.

The prevalence of cardiovascular diseases has propelled developments in the healthcare sector, and various healthcare facilities across the country have increased the number of services. Moreover, the hemodynamic monitoring system assist to offers better and advanced services to the majority of the patients that are admitted to intensive care units and are suffering from cardiovascular diseases. High blood pressure and diabetes are the primary causes of cardiovascular diseases. Hemodynamic monitoring systems offer vital information on cardiovascular activities. In addition, hemodynamic monitoring system has become important tool for diagnosis, it also assists in therapies to guide patients living with tissue hypoperfusion conditions.

In 2019, by type invasive hemodynamic monitoring system accounted for the largest market share in the US hemodynamic monitoring system market. However, the noninvasive hemodynamic monitoring system segment is expected to have faster growth during the forecast period. By, product, disposables segment held largest market in the US hemodynamic monitoring system market. Whereas, the monitors segment is expected to grow at a fastest CAGR.

Similarly, in 2019, the hospitals segment held the most significant market share of the US hemodynamic monitoring system market by the end user. This segment is also anticipated to hold a considerable portion of the market in 2027, owing to the need for hospitals as primary healthcare centers for the people. The segment is also anticipated to witness fastest growth at a significant rate during the forecast period.

Some of the significant primary and secondary sources for US hemodynamic monitoring system market included in the report are National Cardiovascular Data Registry, Food and Drug Administration (FDA),